IdB 1016 in Hepatitis C.

Trial Profile

IdB 1016 in Hepatitis C.

Phase of Trial: Phase I/II

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Silipide (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Sep 2006 Status change
    • 01 Sep 2006 The expected completion date for this trial is now .
    • 03 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top